Vaxcyte, Inc.
- PCVX
- NASDAQ
- Biotechnology
- Vaccine Development (Pneumococcal)
$64.28
Today +1.04%Quote Oct 19, 2026, 01:55 PM UTC
+5.38%over the last month
Max drawdown −13.8%From 1-month high −13.8%3 months +14.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$9.86B
Quote Oct 19
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$122.33
+90.3% from here
Floor
$63.50
1.2% below price
Where the price sits
11 analysts
Analyst range, low to high
$120.00$125.00
- Price $64.28
- Resistance $72.88–$73.61
- Consensus $122.33
The price is just above its floor. Analysts' average target sits about 90% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PCVXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
507
Founded
2013